Cargando…
Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy
Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037369/ https://www.ncbi.nlm.nih.gov/pubmed/33805111 http://dx.doi.org/10.3390/jcm10071347 |
_version_ | 1783677127523041280 |
---|---|
author | Ciampi, Quirino Olivotto, Iacopo Peteiro, Jesus D’Alfonso, Maria Grazia Mori, Fabio Tassetti, Luigi Milazzo, Alessandra Monserrat, Lorenzo Fernandez, Xusto Pálinkás, Attila Pálinkás, Eszter Dalma Sepp, Róbert Re, Federica Cortigiani, Lauro Tesic, Milorad Djordjevic-Dikic, Ana Beleslin, Branko Losi, Mariangela Canciello, Grazia Betocchi, Sandro Lopes, Luis Rocha Cruz, Ines Cotrim, Carlos Torres, Marco A. R. Bellagamba, Clarissa C. A. Van De Heyning, Caroline M. Varga, Albert Ágoston, Gergely Villari, Bruno Lorenzoni, Valentina Carpeggiani, Clara Picano, Eugenio |
author_facet | Ciampi, Quirino Olivotto, Iacopo Peteiro, Jesus D’Alfonso, Maria Grazia Mori, Fabio Tassetti, Luigi Milazzo, Alessandra Monserrat, Lorenzo Fernandez, Xusto Pálinkás, Attila Pálinkás, Eszter Dalma Sepp, Róbert Re, Federica Cortigiani, Lauro Tesic, Milorad Djordjevic-Dikic, Ana Beleslin, Branko Losi, Mariangela Canciello, Grazia Betocchi, Sandro Lopes, Luis Rocha Cruz, Ines Cotrim, Carlos Torres, Marco A. R. Bellagamba, Clarissa C. A. Van De Heyning, Caroline M. Varga, Albert Ágoston, Gergely Villari, Bruno Lorenzoni, Valentina Carpeggiani, Clara Picano, Eugenio |
author_sort | Ciampi, Quirino |
collection | PubMed |
description | Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (≥50 mmHg) in 281 (30.4%). HRR was 1.90 ± 0.40 (lowest quartile ≤ 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018–1.036, p < 0.001), older age (odds ratio 1.021, 95% CI: 1.009–1.033, p < 0.001), lower exercise tolerance (mets, odds ratio 0.761, 95% CI: 0.708–0.817, p < 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043–2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36–145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116–4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441–7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043–1.085 p < 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037–1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients. |
format | Online Article Text |
id | pubmed-8037369 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80373692021-04-12 Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy Ciampi, Quirino Olivotto, Iacopo Peteiro, Jesus D’Alfonso, Maria Grazia Mori, Fabio Tassetti, Luigi Milazzo, Alessandra Monserrat, Lorenzo Fernandez, Xusto Pálinkás, Attila Pálinkás, Eszter Dalma Sepp, Róbert Re, Federica Cortigiani, Lauro Tesic, Milorad Djordjevic-Dikic, Ana Beleslin, Branko Losi, Mariangela Canciello, Grazia Betocchi, Sandro Lopes, Luis Rocha Cruz, Ines Cotrim, Carlos Torres, Marco A. R. Bellagamba, Clarissa C. A. Van De Heyning, Caroline M. Varga, Albert Ágoston, Gergely Villari, Bruno Lorenzoni, Valentina Carpeggiani, Clara Picano, Eugenio J Clin Med Article Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (≥50 mmHg) in 281 (30.4%). HRR was 1.90 ± 0.40 (lowest quartile ≤ 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018–1.036, p < 0.001), older age (odds ratio 1.021, 95% CI: 1.009–1.033, p < 0.001), lower exercise tolerance (mets, odds ratio 0.761, 95% CI: 0.708–0.817, p < 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043–2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36–145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116–4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441–7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043–1.085 p < 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037–1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients. MDPI 2021-03-24 /pmc/articles/PMC8037369/ /pubmed/33805111 http://dx.doi.org/10.3390/jcm10071347 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Article Ciampi, Quirino Olivotto, Iacopo Peteiro, Jesus D’Alfonso, Maria Grazia Mori, Fabio Tassetti, Luigi Milazzo, Alessandra Monserrat, Lorenzo Fernandez, Xusto Pálinkás, Attila Pálinkás, Eszter Dalma Sepp, Róbert Re, Federica Cortigiani, Lauro Tesic, Milorad Djordjevic-Dikic, Ana Beleslin, Branko Losi, Mariangela Canciello, Grazia Betocchi, Sandro Lopes, Luis Rocha Cruz, Ines Cotrim, Carlos Torres, Marco A. R. Bellagamba, Clarissa C. A. Van De Heyning, Caroline M. Varga, Albert Ágoston, Gergely Villari, Bruno Lorenzoni, Valentina Carpeggiani, Clara Picano, Eugenio Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title | Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title_full | Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title_fullStr | Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title_full_unstemmed | Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title_short | Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy |
title_sort | prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037369/ https://www.ncbi.nlm.nih.gov/pubmed/33805111 http://dx.doi.org/10.3390/jcm10071347 |
work_keys_str_mv | AT ciampiquirino prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT olivottoiacopo prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT peteirojesus prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT dalfonsomariagrazia prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT morifabio prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT tassettiluigi prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT milazzoalessandra prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT monserratlorenzo prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT fernandezxusto prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT palinkasattila prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT palinkaseszterdalma prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT sepprobert prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT refederica prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT cortigianilauro prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT tesicmilorad prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT djordjevicdikicana prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT beleslinbranko prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT losimariangela prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT canciellograzia prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT betocchisandro prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT lopesluisrocha prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT cruzines prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT cotrimcarlos prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT torresmarcoar prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT bellagambaclarissaca prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT vandeheyningcarolinem prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT vargaalbert prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT agostongergely prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT villaribruno prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT lorenzonivalentina prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT carpeggianiclara prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT picanoeugenio prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy AT prognosticvalueofreducedheartratereserveduringexerciseinhypertrophiccardiomyopathy |